asp8302
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 14, 2017 (NCT03361540)
Timeline
Indications
Mechanism of action
- Muscarinic acetylcholine receptor M3ACTIVATOR
CHRM3 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03702777 | Phase 2 | Oct 31, 2018 | Astellas |
| NCT03361540 | Phase 1 | Nov 14, 2017 | Astellas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1